Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Carlos Ramirez Neyra

Oral & Maxillofacial Surgery Warren, MI Medical Doctor

NPI 1023230927 CMS profile 449505

11900 E 12 Mile Rd Ste 308, Warren, MI 48093

Open in the dashboard

General payments

$233,092

234 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Carlos Ramirez Neyra of Warren, MI is reported in the CMS Open Payments database as having received $233,092 across 234 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $56,792 66
2024 General $87,147 75
2023 General $80,375 54
2022 General $4,701 17
2021 General $1,015 5
2020 General $139 3
2019 General $2,923 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Carlos Ramirez Neyra
  • Oral & Maxillofacial Surgery median
  • Middle half of Oral & Maxillofacial Surgery
  • National median

In program year 2025, general payments to Carlos Ramirez Neyra were reported at $56,792. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.

Show as a table
Year Carlos Ramirez Neyra Oral & Maxillofacial Surgery median Middle half National median
2019 $2,923 $178 $56–$584 $163
2020 $139 $106 $38–$316 $114
2021 $1,015 $165 $57–$511 $132
2022 $4,701 $173 $63–$494 $149
2023 $80,375 $184 $62–$521 $160
2024 $87,147 $197 $65–$603 $164
2025 $56,792 $184 $61–$541 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Aroa Biosurgery Incorporated $213,602 133 payments
  2. KLS-Martin L.P. $6,004 18 payments
  3. Straumann USA LLC $4,448 1 payment
  4. AxoGen $3,981 22 payments
  5. Stryker Corporation $1,435 13 payments
  6. DePuy Synthes Sales Inc. $1,071 12 payments
  7. TissueTech, Inc. $1,014 5 payments
  8. Smith+Nephew, Inc. $236 5 payments
  9. Urgo Medical North America, LLC $234 2 payments
  10. Inari Medical, Inc. $169 1 payment
  11. Other $898 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $96,900 16 payments
  2. Consulting Fee $90,045 17 payments
  3. Travel and Lodging $25,622 44 payments
  4. Food and Beverage $12,327 154 payments
  5. Debt forgiveness $4,448 1 payment
  6. Honoraria $3,750 2 payments
Products named General payments · program years 2019–2025
  1. AXOGUARD NERVE PROTECTOR $3,186 15 payments
  2. AxoGuard Nerve Connector $3,186 15 payments
  3. Avance Nerve Graft $1,080 9 payments
  4. TRUMATCH $921 10 payments
  5. NA Neuro $834 5 payments
  6. NA Craniomaxillofacial $578 7 payments
  7. NA Craniomaxillofacial $297 3 payments
  8. MATRIXMANDIBLE $272 2 payments
  9. RENASYS Touch $262 3 payments
  10. VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP $234 2 payments
  11. Other $3,312 55 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$56,617

Medicare's payments for the services billed

Medicare patients

167

Average age 73

Services billed

450

86 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 47%
Ischemic heart disease 32%
Diabetes 31%
COPD 26%
Depression 26%
Cancer 23%
Chronic kidney disease 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

234 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Oral & Maxillofacial Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record